BRNS
Barinthus Biotherapeutics
BRNS
BRNS
15 hedge funds and large institutions have $42.4M invested in Barinthus Biotherapeutics in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 0 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
30% less capital invested
Capital invested by funds: $60.2M → $42.4M (-$17.8M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 6
Holders
15
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$6.03M | |
| 2 | +$1.2M | |
| 3 | +$6K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$6K |
Top Sellers
| 1 | -$5.73M | |
| 2 | -$1.64M | |
| 3 | -$630K | |
| 4 |
Millennium Management
New York
|
-$526K |
| 5 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$325K |